Diagnosis of metastatic cancer by the mts-1 gene

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) C07K 14/47 (2006.01) C07K 16/18 (2006.01) C12N 1/19 (2006.01) C12N 1/21 (2006.01) C12N 5/10 (2006.01) C12P 21/08 (2006.01) C12Q 1/68 (2006.01) G01N 33/574 (2006.01) G01N 33/577 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2086829

2086829 9200757 PCTABS00010 The present invention is directed towards the diagnosis of malignant cancer by detection of the mts-1 mRNA or the mts-1 protein, encoded by the mts-1 gene. The present invention contemplates the use of recombinant mts-1 DNA and antibodies directed against the mts-1 protein to diagnose the metastatic potential of several types of tumor cells, including, for example, thyroid, epithelial, lung, liver and kidney tumor cells. The present invention is also directed to mammalian cell lines and tumors with high and low metastatic potential which have been developed to serve as useful model systems for in vitro and in vivo anti-metastasis drug screening.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Diagnosis of metastatic cancer by the mts-1 gene does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnosis of metastatic cancer by the mts-1 gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosis of metastatic cancer by the mts-1 gene will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1775132

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.